
    
      Primary Objective: To assess the safety and feasibility of the Uriprene® Stent by assessing
      the time to complete degradation or the passage of stent fragments from the bladder by
      radiological assessment.

      Subject Population: Patients with clinical symptoms consistent with unilateral ureteral or
      renal stone fragments ≤ 2mm, post-uncomplicated ureteroscopy (UURS).
    
  